Kezar Life Sciences, Inc.KZR

Market cap

$46.17M

P/E ratio

	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Cash and cash equivalents	24	15	21	63	40	35	42
Marketable securities	83	63	119	145	236	166	90
Prepaid expenses and other current assets	-	-	-	-	-	6	5
Total current assets	110	81	145	212	286	207	137
Property and equipment, net	5	4	3	3	3	4	3
Operating lease right-of-use asset	-	4	3	3	10	5	2
Other assets	0	0	0	0	1	6	2
Total assets	115	90	152	218	300	221	145
Accounts payable	0	1	2	2	2	8	4
Accrued liabilities	3	4	3	5	6	6	8
Operating Lease, Liability, Current	-	1	1	1	3	3	4
Debt, current	-	-	-	-	-	-	5
Total current liabilities	3	6	6	8	11	18	20
Operating Lease, Liability, Noncurrent	-	5	4	3	9	6	2
Debt, noncurrent	-	-	-	10	10	10	5
Total liabilities	6	11	11	21	30	34	28
Common Stock, Value, Issued	0	0	0	0	0	0	0
Additional paid-in capital	158	163	267	378	520	538	552
Accumulated other comprehensive loss	-0	-0	-0	-0	-1	-0	-0
Accumulated deficit	-49	-84	-126	-181	-249	-351	-434
Total stockholders' equity	109	78	141	197	270	188	117
Total liabilities and stockholders' equity	115	90	152	218	300	221	145